Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 26 for “"leukemia stem cell"”.
-
Characterization of the anti-leukemia stem cell activity of chaetocin
Chronic myelogenous leukemia is a myeloproliferative hematopoietic stem cell disease resulting from a reciprocal translocation that gives rise to BCR-ABL, a constitutively active tyrosine kinase. Imatinib and other tyrosine kinase inhibitors are currently standard therapy; however, point mutations …
-
Leukemia Stem Cell Markers And Inv(16) In Acute Myeloid Leukemia
… greater than 85% of inv(16) acute myeloid leukemia patients are able to achieve first complete remission after anthracycline- and cytarabine-based therapy, only about 60% of patients survive the disease long-term due to relapsed disease or treatment-related mortality. Multiple studies have …
-
Identifying Stress Granules as Determinants of Leukemia Stem Cell Maintenance and Stress Adaptation
The development of novel leukemic stem cell (LSC)-targeted therapeutics is an urgent goal towards reducing the high, LSC-driven relapse rates in acute myeloid leukemia (AML) patients. Towards elucidating key LSC dependencies we performed an in vivo CRISPR dropout screen targeting RNA binding …
-
The Role of the Bone Marrow Microenvironment in FLT3-ITD Acute Myeloid Leukemia Stem Cell Resistance to FLT3 Inhibition
Acute myeloid leukemia (AML) is an aggressive, complex hematological malignancy. AML cases with constitutively-activating internal tandem duplications in the Flt3 receptor (Flt3-ITD) represent a distinct subtype of disease with poor prognosis, but unique opportunities for targeted therapy. …
-
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Acute Myeloid Leukemia
… as a therapeutic strategy for acute myeloid leukemia Marko Škrtić Doctor of Philosophy Institute of Medical Science University of Toronto 2012 Abstract Intro: Acute myeloid leukemia (AML) therapies have remained unchanged for 20 years, and thus new therapies are needed. Objective: To identify …
-
Cord Blood CD34+ Expansion Using Vitamin-C: An Epigenetic Regulator
… (Vit-C) has been shown to modulate hematopoietic stem cells and leukemia stem cell frequency in-vivo. Herein, Vit-C analogue, L-ascorbic acid 2-phosphate (AA2P), was investigated as a new potential HSC expansion agonist. Cord blood CD34+ cells were expanded in cultures with or without AA2P. AA2P …
-
Multigradient hydrogels to decode extrinsic regulation of hematopoietic stem cell fate
… for the generation of all the blood and immune cells of the body. The cells responsible for this process are the hematopoietic stem cells (HSCs), primarily located within the bone marrow. They are housed in specific microenvironments (niches) that provide stochastically and temporally mutable …
-
An ECM-based model derived from DWJM to study hematopoiesis and leukemia
Hematopoietic stem cells (HSCs) are responsible for the generation of the body’s whole blood and immune cells. This process occurs mainly within the bone marrow microenvironment, known as the "niche", which provides signals to regulate HSC survival, quiescence, self-renewal, and differentiation. …
-
Characterization and Control of Leukemia Stem Cells in Acute Myeloid Leukemia
… is to explore the potential application of leukemia stem cell (LSC) properties for improving the treatment and management of adults with acute myeloid leukemia (AML), solidifying the clinical relevance of functional stem cell frequency estimates from xenotransplantation assays to human …
-
Mechanisms of progression of myelodysplastic syndrome to fatal secondary acute myeloid leukemia
Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are complex disorders of the blood-forming system that arise when mutations accumulate in stem/progenitor cells, giving them abnormal growth or survival advantages. Although MDS and AML are classified as separate diseases, determined …
-
Identifying Novel Therapeutic Targets in Acute Myeloid Leukemia
Though most acute myeloid leukemia (AML) patients achieve complete remissions (CRs) with standard induction chemotherapy, the majority subsequently relapse and die from the disease. My thesis studies revolved around better understanding the biology of AML with an eye to prevent these relapses. I …
-
Role of Autocrine and Paracrine WNT Signaling in Chronic Myeloid Leukemia Stem Cells
Treatment of chronic myeloid leukemia (CML) with BCR-ABL tyrosine kinase inhibitors (TKIs) fails to eradicate the leukemia stem cells (LSCs) from which the disease arises. Previously, we and others have shown that LSC persistence is related to kinase-independent mechanisms and mediated in part by …
-
Epigenetic basis of stem cell identity in normal and malignant hematopoietic development
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by subpopulations of leukemia-initiating or leukemia stem cells (LSC) that give rise to clonally related non-stem leukemic blasts. The LSC model proposes that since LSC and their blast progeny are clonally related, …
-
METHYLATION OF LEUKEMIA STEM CELLS AND THEIR PROGENY IN ACUTE MYELOID LEUKEMIA
Acute myeloid leukemia (AML) is characterized by abnormal differentiation of the myeloid cell lineage leading to unchecked clonal expansion of myeloid blast cells. Evidence suggests that AML is organized in a hierarchical fashion similar to that observed in normal hematopoiesis. Leukemia stem cells …
-
INTEGRATED SINGLE-CELL MUTATION, GENE EXPRESSION AND ISOFORM ANALYSIS TO DECONVOLVE ACUTE MYELOID LEUKEMIA HETEROGENEITY
Acute myeloid leukemia (AML) is an aggressive cancer arising from the hematopoietic stem cell (HSC). As other tumor types, AMLs are characterized by multiple and interconnected levels of intra-tumor heterogeneity, including genetic (DNA mutations), phenotypic (transcriptional patterns) and …
-
WNT-DEPENDENT REGENERATIVE FUNCTION IS INDUCED IN LEUKEMIA-INITIATING AC133BRIGHT CELLS
The Cancer Stem Cell model supported the notion that leukemia was initiated and maintained in vivo by a small fraction of leukemia-initiating cells (LICs). Previous studies have suggested the involvement of Wnt signaling pathway in Acute Myeloid Leukemia (AML) by the ability to sustain the …
-
Identification of additional genetic alterations in RUNX1 related leukemias
… is essential for the generation of hematopoietic stem cells (HSC) and is the most frequently mutated gene in human leukemia. Conditional deletion of Runx1 in adult mice results in an increase of HSC which serve as the target cell pool for leukemia; however, Runx1-/- mice do not develop spontaneous …
-
Clinical relevance of WNT10B / WNT10BIVS1 allele variant expression and its potential in Acute Myeloid Leukemia risk assessment
Acute myeloid leukemia (AML) develops as the consequence of a series of genetic changes in a hematopoietic precursor cell, that alter normal hematopoietic growth and differentiation, resulting in an accumulation of large numbers of abnormal, immature myeloid cells in the bone marrow and peripheral …
-
Functional Screens Identify Vulnerabilities in Acute Leukemia
Acute leukemia refers to a group of aggressive hematological malignancies of myeloid and lymphoid lineages termed acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL) respectively. Acute leukemia is characterized by the presence of underlying genetic aberrations which alter the biology of …
-
CRISPR Screens Identify Candidate Therapeutic Targets in Leukemia
Acute myeloid leukemia (AML) is a complex hematological malignancy marked by proliferation of immature myeloid cells with a dismal 5-year survival. A major challenge is the persistence of leukemia stem cells (LSCs) after standard treatment, leading to relapse. This thesis employs in vivo …
Page 1 of 2